2016 ACBS Landline-Cellphone Combined Prevalence Tables
BRFSS Asthma Call-back Survey Prevalence TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey, United States, 2016.
| State/Territory | Current | Active | ||||||
|---|---|---|---|---|---|---|---|---|
| Sample size± |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | |
| Arizona | 331 | 56.8 | 4.7 | (47.6 – 66.0) | 352 | 55.8 | 4.5 | (47.0 – 64.6) |
| California | 234 | 57.6 | 4.3 | (49.2 – 66.0) | 263 | 51.9 | 4.1 | (43.9 – 59.9) |
| Connecticut | 294 | 55.2 | 4.4 | (46.6 – 63.8) | 315 | 52.4 | 4.3 | (44.0 – 60.8) |
| Florida | 888 | 36.6 | 3.6 | (29.5 – 43.7) | 967 | 35.1 | 3.4 | (28.4 – 41.8) |
| Georgia | 150 | 35.5 | 5.3 | (25.1 – 45.9) | 157 | 33.4 | 5.1 | (23.4 – 43.4) |
| Hawaii | 218 | 42.4 | 5.1 | (32.4 – 52.4) | 248 | 38.6 | 4.9 | (29.0 – 48.2) |
| Illinois | 168 | 54.3 | 5.1 | (44.3 – 64.3) | 175 | 51.1 | 5.4 | (40.5 – 61.7) |
| Indiana | 436 | 57.3 | 3.8 | (49.9 – 64.7) | 466 | 54.1 | 3.7 | (46.8 – 61.4) |
| Iowa | 177 | 52.3 | 5.7 | (41.1 – 63.5) | 187 | 52.5 | 5.4 | (41.9 – 63.1) |
| Kansas | 370 | 47.1 | 3.9 | (39.5 – 54.7) | 390 | 48.4 | 3.8 | (41.0 – 55.8) |
| Maine | 546 | 58.7 | 3.4 | (52.0 – 65.4) | 578 | 58.1 | 3.3 | (51.6 – 64.6) |
| Massachusetts | 201 | 53.8 | 5.4 | (43.2 – 64.4) | 216 | 51.5 | 5.1 | (41.5 – 61.5) |
| Michigan | 614 | 54.4 | 2.9 | (48.7 – 60.1) | 657 | 54.3 | 2.8 | (48.8 – 59.8) |
| Minnesota | 551 | 55.9 | 2.6 | (50.8 – 61.0) | 604 | 50.9 | 2.6 | (45.8 – 56.0) |
| Missouri | 252 | 66.1 | 5.2 | (55.9 – 76.3) | 280 | 58.7 | 5.7 | (47.5 – 69.9) |
| Montana | 181 | 55.7 | 6.2 | (43.5 – 67.9) | 194 | 56.7 | 5.8 | (45.3 – 68.1) |
| Nebraska | 440 | 53.6 | 4.7 | (44.4 – 62.8) | 466 | 53.1 | 4.4 | (44.5 – 61.7) |
| Nevada | 151 | 47.1 | 6.8 | (33.8 – 60.4) | 157 | 46.0 | 6.6 | (33.1 – 58.9) |
| New Hampshire | 203 | 62.5 | 5.2 | (52.3 – 72.7) | 220 | 57.7 | 5.2 | (47.5 – 67.9) |
| New Jersey | 255 | 39.1 | 7.1 | (25.2 – 53.0) | 291 | 41.1 | 6.6 | (28.2 – 54.0) |
| New Mexico | 201 | 40.8 | 5.3 | (30.4 – 51.2) | 210 | 39.4 | 5.2 | (29.2 – 49.6) |
| New York | 425 | 58.3 | 5.6 | (47.3 – 69.3) | 460 | 53.1 | 5.1 | (43.1 – 63.1) |
| Ohio | 423 | 51.2 | 3.9 | (43.6 – 58.8) | 447 | 50.1 | 3.8 | (42.7 – 57.5) |
| Oklahoma | 145 | 44.7 | 6.9 | (31.2 – 58.2) | 153 | 42.5 | 6.5 | (29.8 – 55.2) |
| Oregon | 145 | 63.2 | 4.8 | (53.8 – 72.6) | 165 | 58.0 | 4.5 | (49.2 – 66.8) |
| Pennsylvania | 249 | 44.1 | 4.4 | (35.5 – 52.7) | 260 | 44.0 | 4.3 | (35.6 – 52.4) |
| Rhode Island | 175 | 55.9 | 6.4 | (43.4 – 68.4) | 188 | 52.9 | 6.2 | (40.7 – 65.1) |
| Texas | 348 | 40.8 | 4.8 | (31.4 – 50.2) | 373 | 35.3 | 4.4 | (26.7 – 43.9) |
| Utah | 300 | 47.6 | 4.3 | (39.2 – 56.0) | 333 | 45.5 | 3.9 | (37.9 – 53.1) |
| Vermont | 231 | 62.6 | 4.7 | (53.4 – 71.8) | 243 | 60.3 | 4.6 | (51.3 – 69.3) |
| Wisconsin | 203 | 47.1 | 5.1 | (37.1 – 57.1) | 220 | 47.8 | 4.9 | (38.2 – 57.4) |
| Puerto Rico | 284 | 26.5 | 3.5 | (19.6 – 33.4) | 326 | 24.9 | 3.2 | (18.6 – 31.2) |
| 32 states / area | 9,789 | 50.5 | 1.1 | (48.3 – 52.7) | 10,561 | 47.6 | 1.1 | (45.4 – 49.8) |
| Median | 53.7 | 51.3 | ||||||
| Range | 26.5-66.1 | 24.9-60.3 | ||||||
1 Aged ≥ 18 years
2 “Yes” response to “Do you still have asthma?”
3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
± Landline and cell phone combined sample size excludes “DK/Refused”
§ Standard error
† Confidence interval
Link for Summary Data Quality Report: https://www.cdc.gov/brfss/acbs/2016/pdf/sdq_report_acbs_16-508.pdfpdf icon
Page last reviewed: February 19, 2020